Erythrocytes deliver Tat to interferon-γ-treated human dendritic cells for efficient initiation of specific type 1 immune responses in vitro

Journal of Leukocyte Biology

Volumn 71, Issue 4, 2002, Pages 652-658

  Corinti, Silvia ^a   Chiarantini, Laura ^b   Dominici, Sabrina ^b   Laguardia, Maria Elena ^b   Magnani, Mauro ^b   Girolomoni, Giampiero ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^b UNIVERSITY OF URBINO   (Italy)

Author keywords

AIDS; Chemokines; Cytokines; T lymphocytes; Vaccination

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 12; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TRANSACTIVATOR PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CELL CULTURE; CELL FUNCTION; CELL MATURATION; CULTURE MEDIUM; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; ERYTHROCYTE; HUMAN; HUMAN CELL; INTERNALIZATION; LYMPHOCYTE PROLIFERATION; MONOCYTE; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; PROTEIN SECRETION; TH1 CELL; TH2 CELL; VACCINATION; VIRUS INFECTION;

CHEMOKINES; CYTOKINES; DENDRITIC CELLS; ERYTHROCYTES; GENE PRODUCTS, TAT; HIV INFECTIONS; HUMANS; INTERFERON TYPE II; T-LYMPHOCYTES;

EID: 0036553910     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Banchereau, J., Steinman, R. M. (1998) Dendritic cells and the control of immunity. Nature 392, 245-252.
2. Lanzavecchia, A., Sallusto, F. (2000) Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science 290, 92-97.
3. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y-J., Pulendran, B., Palucka, K. (2000) Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767-811.
4. Gallucci, S., Matzinger, P. (2001) Danger signals: SOS to the immune system. Curr. Opin. Immunol. 13, 114-119.
5. Kitajima, T., Caceres-Dittmar, G., Tapia, F. J., Jester, J., Bergstresser, P. R., Takashima, A. (1996) T-cell mediated terminal maturation of dendritic cells. J. Immunol. 157, 2340-2347.
6. Snijders, A., Kalinski, P., Hilkens, C. M., Kapsenberg, M. L. (1998) High-level IL-12 production by human dendritic cells requires two signals. Int. Immunol. 10, 1593-1598.
7. Hochrein, H., O'Keeffe, M., Luft, T., Vandenabeele, S., Grumont, R. J., Maraskowsky, E., Shortman, K. (2000) Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells. J. Exp. Med. 192, 823-833.
8. Fong, L., Engleman, E. G. (2000) Dendritic cells in cancer immunotherapy. Annu. Rev. Immunol. 18, 245-273.
9. Dhodapkar, M. V., Bhardwaj, N. (2000) Active immunization of humans with dendritic cells. J. Clin. Immunol. 20, 167-174.
10. Nestle, F. O., Bancherau, J., Hart, D. (2001) Dendritic cells: on the move from bench to bedside. Nat. Med. 7, 761-765.
11. + T-cell responses from chronically infected individuals. J. Virol. 75, 2142-2153.
12. Jondal, M., Schrimbeck, R., Reimann, J. (1996) MHC class I-restricted CTL responses to exogenous antigens. Immunity 5, 295-302.
13. Goletz, T. J., Klimpel, K. R., Leppla, S. H., Keith, J. M., Berzofsky, J. A. (1997) Delivery of antigens to the MHC class I pathway using bacterial toxins. Hum. Immunol. 54, 129-136.
14. Jenne, L., Schuler, G., Steinkasserer, A. (2001) Viral vectors for dendritic cell-based immunotherapy. Trends Immunol. 22, 102-107.
15. + T-cell responses in vivo. Blood 96, 3505-3513.
16. + T lymphocytes. J. Immunol. 163, 3029-3036.
17. Albert, M. L., Sauter, B., Bhardwaj, N. (1998) Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392, 86-89.
18. Inaba, K., Turley, S., Yamaide, F., Iyoda, T., Mahnke, K., Inaba, M., Pack, M., Subklewe, M., Sauter, B., Sheff, D., Albert, M., Bhardwaj, N., Mellman, I., Steinman, R. M. (1998) Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J. Exp. Med. 188, 2163-2173.
19. Magnani, M., Chiarantini, L., Mancini, U. (1994). Preparation and characterization of biotinylated red blood cells. Biotechnol. Appl. Biochem. 20, 335-345.
20. Chiarantini, L., Argnani, R., Zucchini, S., Stevanata, L., Zabordi, P., Grossi, M. P., Magnani, M., Manservigi, R. (1997). Red blood cells as delivery system for recombinant HSV-1 glycoprotein B: immunogenicity and protection in mice. Vaccine 15, 276-280.
21. Chiarantini, L., Matteucci, D., Pistello, M., Mancini, U., Mazzetti, P., Massi, C., Giannecchini, S., Lonetti, I., Magnani, M., Bendinelli, M. (1998). AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: homologous erythrocytes as a delivery system for preferential immunization with putative protective antigens. Clin. Diagn. Lab. Immunol. 5, 235-241.
22. + T helper cells in the cytotoxic T lymphocyte response to HIV-1. Curr. Opin. Immunol. 12, 375-380.
23. Dhodapkar, M. V., Steinman, R. M., Sapp, M., Desai, H., Fossella, C., Krasovsky, J., Donahoe, S. M., Dunbar, P. R., Cerundolo, V., Nixon, D. F., Bhardwaj, N. (1999) Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells. J. Clin. Investig. 104, 173-180.
24. Chiarantini, L., Magnani, M. (1996) Immobilization of enzymes and proteins on red blood cells. In Methods in Biotechnology. Immobilization of Enzymes and Cells (G. Bickerstaff, ed.), Totowa, NJ, Humana, 143-152.
25. + T-cell lines. Immunology 87, 310-316.
26. Jonuleit, H., Kühn, U., Müller, G., Steinbrink, K., Paragnik, L., Schmitt, E., Knop, J., Enk, A. H. (1997) Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur. J. Immunol. 27, 3135-3142.
27. Henderson, R. A., Watkins, S. C., Flynn, J. L. (1997) Activation of human dendritic cells following infection with Mycobacterium tuberculosis. J. Immunol. 159, 635-643.
28. Gangur, V., Simons, F. E. R., Hayglass, K. T. (1998) Human IP-10 selectively promotes dominance of polyclonally activated and environmental antigen-driven IFN-γ over IL-4 responses. FASEB J. 12, 705-713.
29. Vulcano, M., Albanesi, C., Stoppacciaro, A., Bagnati, R., D'Amico, G., Struyf, S., Transidico, P., Bonecchi, R., Del Prete, A., Allavena, P., Ruco, L. P., Chiabrando, C., Girolomoni, G., Mantovani, A., Sozzani, S. (2001). Dendritic cells as a major source of macrophage-derived chemokine/ CCL22 in vitro and in vivo. Eur. J. Immunol. 31, 812-822.
30. McMichael, A. J., Rowland-Jones, S. L. (2001) Cellular immune responses to HIV. Nature 410, 980-987.
31. Meylan, P. R., Guatelli, J. C., Munis, J. R., Richman, D. D., Kornbluth, R. S. (1993). Mechanisms for the inhibition of HIV replication by interferons-α, -β, and -γ in primary human macrophages. Virology 193, 138-148.
32. Emilie, D., Maillot, M. C., Nicolas, J. F., Fior, R., Galanaud, P. (1992) Antagonistic effect of interferon-gamma on Tat-induced transactivation of HIV long terminal repeat. J. Biol. Chem. 267, 20565-20570.
33. Goldstein, G. (1996) HIV-1 Tat protein as a potential AIDS vaccine. Nat. Med. 2, 960-964.
34. Gallo, R. C. (1999) Tat as one key to HIV-induced immune pathogenesis and Tat toxoid as an important component of a vaccine. Proc. Natl. Acad. Sci. USA 96, 8324-8326.
35. Allen, T. M., O'Connor, D. H., Jing, P., Dzuris, J. L., Mothe, B. R., Vogel, T. U., Dunphy, E., Liebl, M. E., Emerson, C., Wilson, N., Kunstman, K. J., Wang, X., Allison, D. B., Hughes, A. L., Desrosiers, R. C., Altman, J. D., Wolinsky, S. M., Sette, A., Watkins, D. I. (2000) Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia. Nature 407, 386-390.
36. Cafaro, A., Caputo, A., Fracasso, C., Maggiorella, M. T., Goletti, D., Baroncelli, S., Pace, M., Sernicola, L., Koanga-Mogtomo, M. L., Betti, M., Borsetti, A., Belli, R., Åkerblom, L., Corrias, F., Butto, S., Heeney, J., Verani, P., Titti, F., Ensoli, B. (1999) Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine. Nat. Med. 5, 643-650.
37. Pauza, C. D., Trivedi, P., Wallace, M., Ruckwardt, T. J., Le Buanec, H., Lu, W., Bizzini, B., Burny, A., Zagury, D., Gallo, R. C. (2000) Vaccination with Tat toxoid attenuates disease in simian/HIV-challenged macaques. Proc. Natl. Acad. Sci. USA 97, 3515-3519.
38. Cohen, S. S., Li, C., Ding, L., Cao, Y., Pardee, A. B., Shevach, E. M., Cohen, D. I. (1999) Pronounced acute immunosuppression in vivo mediated by HIV Tat challenge. Proc. Natl. Acad. Sci. USA 96, 10842-10847.
39. Fonseca, A. M., Porto, G., Uchida, K., Arosa, F. A. (2001). Red blood cells inhibit activation-induced cell death and oxidative stress in human peripheral blood T lymphocytes. Blood 97, 3152-3160.
40. + T cells. J. Immunol. 165, 1182-1190.
41. Corinti, S., la Sala, A., Albanesi, C., Pastore, S., Girolomoni, G. (2001) Regulatory activity of autocrine interleukin-10 on dendritic cell functions. J. Immunol. 116, 4312-4318.
42. Nardelli, B., Morahan, D. K., Bong, G. W., Semenuk, M. A., Kreider, B. L., Garotta, G. (1999) Dendritic cells and MPIF-1: chemotactic activity and inhibition of endogenous chemokine production by IFN-γ and CD40 ligation. J. Leukoc. Biol. 65, 822-828.